| CAS NO: | 1122047-98-6 |
| 包装: | 1mg |
| 市场价: | 15300元 |
cis-Clopidogrel-MPDerivative(Clopidogrel-MP-AM)是Clopidogrel活性代谢产物的3'-甲氧基苯乙酮衍生物。Clopidogrel是一种具有口服活性血小板抑制剂，靶向P2Y12受体。
| Cas No. | 1122047-98-6 |
| 别名 | Clopidogrel-MP-AM |
| Canonical SMILES | COC1=CC=CC(C(CSC2CCN([C@H](C(OC)=O)C3=C(Cl)C=CC=C3)C/C2=C/C(O)=O)=O)=C1 |
| 分子式 | C25H26ClNO6S |
| 分子量 | 504 |
| 储存条件 | Store at -20℃ |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | cis-Clopidogrel-MP Derivative (Clopidogrel-MP-AM) is a 3'-methoxyacetophenone derivative of Clopidogrel active metabolite[1]. Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor[2]. [1]. Makoto Takahashi, et al. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. harm Biomed Anal. 2008 Dec 1;48(4):1219-24. [2]. Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan. |
m.cnreagent.com